Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Cheng Tang

1PUBLICATIONS
14CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 12, 2025
In situ DC-primed vaccine combined with CD137 agonist elicits long-lasting antitumor immunity through cDC1-mediated tumor antigen-specific CD8<sup>+</sup> T cell responses.

Mengjiao Wang, Li Qiu, Cheng Tang

Pageof 1

Frequent Collaborators

1 joint publications

Mengjiao Wang

1 joint publications

Li Qiu

1 joint publications

Danqing Huang

1 joint publications

Zunyi Li

1 joint publications

Zhenhui Zhang

1 joint publications

Shupei Wei

1 joint publications

Lanfang Chen

1 joint publications

Hongxin Huang

1 joint publications

Junfeng Zhou

1 joint publications

Tao Lu

Frequent Collaborators

1 joint publications

Mengjiao Wang

1 joint publications

Li Qiu

1 joint publications

Danqing Huang

1 joint publications

Zunyi Li

Top Related Videos

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

1.4K
See more related videos

Top Related Videos

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

1.4K
See more related videos